2022
DOI: 10.21203/rs.3.rs-1724364/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

CXCR6+ tumor-associated macrophages identify immunoevasive colon cancer patients with poor prognosis but favorable response to adjuvant chemotherapy

Abstract: Background For high-risk II stage and III stage colon cancer (CC), the side effects and prognostic benefit of adjuvant chemotherapy need to be balanced. It is well known that tumor-associated macrophages (TAMs) play a key role in tumor progression and exist as heterogenous subpopulations. However, the clinical significance of them remains unknown. Methods Two independent cohorts of 360 and 126 consecutive colon cancer patients were enrolled from two medical centers of Zhongshan Hospital. The association of C… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles